Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Single-centre, Randomised, Observer-blind Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's Monovalent H1N1 Influenza Virus Vaccine in Healthy Adults Aged 18 to < 65 Years.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00938639
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:53.373983+00:00
Published At
2013-11-21T00:00:00+00:00
Record Updated At
2018-06-28
Results Posted At
2013-11-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Influenza Caused by the Novel Influenza A (H1N1) Virus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-28"
protocolSection.identificationModule.nctId
"NCT00938639"
protocolSection.identificationModule.officialTitle
"A Phase II, Single-centre, Randomised, Observer-blind Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL\u0027s Monovalent H1N1 Influenza Virus Vaccine in Healthy Adults Aged 18 to \u003c 65 Years."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-11-21"

Study condition terms

  • Influenza Caused by the Novel Influenza A (H1N1) Virus (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.